GHO Capital-backed ELIQUENT Life Sciences completed the acquisition of Truliant Consulting.

GHO Capital-backed ELIQUENT Life Sciences, a global regulatory, quality, and safety consulting firm, completed the acquisition of Truliant Consulting, a pharmacovigilance, risk management, and regulatory compliance advisory firm. Financial terms were not disclosed. This strategic acquisition reinforces ELIQUENT’s position as a premier provider of end-to-end support for every stage of the product lifecycle.